학술논문
A3 - Germline variants and clinical outcomes of high-risk stage II and stage III colon cancer patients treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy: a pharmacogenetic ancillary study to TOSCA trial
Document Type
Abstract
Author
Source
In Annals of Oncology October 2017 28 Supplement 6:vi3-vi4
Subject
Language
ISSN
0923-7534